SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Schnitt SJ. The diagnosis and management of pre-invasive breast disease: flat epithelial atypia—classification, pathologic features and clinical significance. Breast Cancer Res. 2003; 5: 263268.
  • 2
    Schnitt SJ,Vincent-Salomon A. Columnar cell lesions of the breast. Adv Anat Pathol. 2003; 10: 113124.
  • 3
    Simpson PT,Gale T,Reis-Filho JS, et al. Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol. 2005; 29: 734746.
  • 4
    David N,Labbe-Devilliers C,Moreau D,Loussouarn D,Campion L. Diagnosis of flat epithelial atypia (FEA) after stereotactic vacuum-assisted biopsy (VAB) of the breast: What is the best management: systematic surgery for all or follow-up? [in French]. J Radiol. 2006; 87(11 pt 1): 16711677.
  • 5
    Kunju LP,Kleer CG. Significance of flat epithelial atypia on mammotome core needle biopsy: should it be excised? Hum Pathol. 2007; 38: 3541.
  • 6
    O'Malley FP,Mohsin SK,Badve S, et al. Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast. Mod Pathol. 2006; 19: 172179.
  • 7
    Pinder SE,Reis-Filho JS. Non-operative breast pathology: columnar cell lesions. J Clin Pathol. 2007; 60: 13071312.
  • 8
    Foote FW,Stewart FW. Comparative studies of cancerous versus noncancerous breasts. Ann Surg. 1945; 121: 197222.
  • 9
    Azzopardi JG,Ahmed A,Millis RR. Problems in breast pathology. Major Probl Pathol. 1979; 11: ixvi,1–466.
  • 10
    Bonser GM. Human and Experimental Breast Cancer. London, UK: Pitman; 1961.
  • 11
    Gallager HS. Treatment selection in primary breast cancer. Pathologic considerations. AJR Am J Roentgenol. 1976; 126: 135138.
  • 12
    Wellings SR,Jensen HM,Marcum RG. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst. 1975; 55: 231273.
  • 13
    Page DL: Columnar alteration of lobules. In: Page DL,Anderson TJ, eds. Diagnostic Histopathology of the Breast. Edinburgh, UK, London, UK, Melbourne, Australia, and New York, NY: Churchill Livingstone; 1987: 8688.
  • 14
    Abdel-Fatah TM,Powe DG,Hodi Z,Lee AH,Reis-Filho JS,Ellis IO. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol. 2007; 31: 417426.
  • 15
    Bratthauer GL,Tavassoli FA. Assessment of lesions coexisting with various grades of ductal intraepithelial neoplasia of the breast. Virchows Arch. 2004; 444: 340344.
  • 16
    Dabbs DJ,Carter G,Fudge M,Peng Y,Swalsky P,Finkelstein S. Molecular alterations in columnar cell lesions of the breast. Mod Pathol. 2006; 19: 344349.
  • 17
    Leibl S,Regitnig P,Moinfar F. Flat epithelial atypia (DIN 1a, atypical columnar change): an underdiagnosed entity very frequently coexisting with lobular neoplasia. Histopathology. 2007; 50: 859865.
  • 18
    Moinfar F,Man YG,Bratthauer GL,Ratschek M,Tavassoli FA. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type (“clinging ductal carcinoma in situ”): a simulator of normal mammary epithelium. Cancer. 2000; 88: 20722081.
  • 19
    Rosen PP. Columnar cell hyperplasia is associated with lobular carcinoma in situ and tubular carcinoma. Am J Surg Pathol. 1999; 23: 1561.
  • 20
    Brogi E,Oyama T,Koerner FC. Atypical cystic lobules in patients with lobular neoplasia. Int J Surg Pathol. 2001; 9: 201206.
  • 21
    Oyama T,Iijima K,Takei H, et al. Atypical cystic lobule of the breast: an early stage of low-grade ductal carcinoma in-situ. Breast Cancer. 2000; 7: 326331.
  • 22
    Goldstein NS,O'Malley BA. Cancerization of small ectatic ducts of the breast by ductal carcinoma in situ cells with apocrine snouts: a lesion associated with tubular carcinoma. Am J Clin Pathol. 1997; 107: 561566.
  • 23
    Fraser JL,Raza S,Chorny K,Connolly JL,Schnitt SJ. Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol. 1998; 22: 15211527.
  • 24
    Guerra-Wallace MM,Christensen WN,White RLJr. A retrospective study of columnar alteration with prominent apical snouts and secretions and the association with cancer. Am J Surg. 2004; 188: 395398.
  • 25
    Tavassoli FA,Devilee P, International Agency for Research on Cancer, World Health Organization. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, France: IAPS Press; 2003.
  • 26
    Lee S,Medina D,Tsimelzon A, et al. Alterations of gene expression in the development of early hyperplastic precursors of breast cancer. Am J Pathol. 2007; 171: 252262.
  • 27
    Bijker N,Peterse JL,Duchateau L, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol. 2001; 19: 22632271.
  • 28
    de Mascarel I,MacGrogan G,Mathoulin-Pelissier S, et al. Epithelial atypia in biopsies performed for microcalcifications. Practical considerations about 2,833 serially sectioned surgical biopsies with a long follow-up. Virchows Arch. 2007; 451: 110.
  • 29
    Eusebi V,Foschini MP,Cook MG,Berrino F,Azzopardi JG. Long-term follow-up of in situ carcinoma of the breast with special emphasis on clinging carcinoma. Semin Diagn Pathol. 1989; 6: 165173.
  • 30
    Martel M,Barron-Rodriguez P,Tolgay Ocal I,Dotto J,Tavassoli FA. Flat DIN 1 (flat epithelial atypia) on core needle biopsy: 63 cases identified retrospectively among 1,751 core biopsies performed over an 8-year period (1992-1999). Virchows Arch. 2007; 451: 883891.
  • 31
    Page DL,Dupont WD,Rogers LW,Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985; 55: 26982708.
  • 32
    Dupont WD,Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985; 312: 146151.
  • 33
    Dupont WD,Page DL,Parl FF, et al. Estrogen replacement therapy in women with a history of proliferative breast disease. Cancer. 1999; 85: 12771283.
  • 34
    Dupont WD,Page DL,Parl FF, et al. Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med. 1994; 331: 1015.
  • 35
    Gobbi H,Dupont WD,Parl FF, et al. Breast cancer risk associated with estrogen receptor expression in epithelial hyperplasia lacking atypia and adjacent lobular units. Int J Cancer. 2005; 113: 857859.
  • 36
    Lubin JH,Gail MH. Biased selection of controls for case-control analyses of cohort studies. Biometrics. 1984; 40: 6375.
  • 37
    McLaren BK,Gobbi H,Schuyler PA, et al. Immunohistochemical expression of estrogen receptor in enlarged lobular units with columnar alteration in benign breast biopsies: a nested case-control study. Am J Surg Pathol. 2005; 29: 105108.
  • 38
    Dupont WD. Statistical Modeling for Biomedical Researchers: A Simple Introduction to the Analysis of Complex Data. Cambridge, UK, New York, NY: Cambridge University Press; 2002.
  • 39
    Dupont WD,Parl FF,Hartmann WH, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer. 1993; 71: 12581265.
  • 40
    London SJ,Connolly JL,Schnitt SJ,Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. JAMA. 1992; 267: 941944.
  • 41
    Page DL,Dupont WD,Rogers LW. Breast cancer risk of lobular-based hyperplasia after biopsy: “ductal” pattern lesions. Cancer Detect Prev. 1986; 9: 441448.
  • 42
    Carter CL,Corle DK,Micozzi MS,Schatzkin A,Taylor PR. A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol. 1988; 128: 467477.
  • 43
    Marshall LM,Hunter DJ,Connolly JL, et al. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev. 1997; 6: 297301.